MACC1 gene is an independent prognostic biomarker for survival in Klatskin tumor patients

(Max Delbrück Center for Molecular Medicine in the Helmholtz Association) Bile duct cancer is rare and is usually detected too late. Often only extensive liver surgery can help or, in rare cases, liver transplantation. But which patients will benefit from surgery and which will not? With the oncogene MACC1 as a biomarker, physicians for the first time have a tool to decide which treatment is best for patients with Klatskin carcinoma, one type of bile duct cancer.
Source: EurekAlert! - Biology - Category: Biology Source Type: news